Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Jul 31, 2017 · 10-Q · 31 days after period end · 0001564590-17-014488
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Net Income | -$169.00K | -$238.00K | -$6.01M | -$7.02M |
| EPS Diluted | -$79.60 | -$11.21 | $0.26 | -$0.47 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Jun 30, 2017 · filed Jul 31, 2017 · 31 d after period end
